FREENOME EXPANDS PERSONALIZED CANCER DETECTION PORTFOLIO, LAUNCHING SIMPLESCREEN™ LUNG TEST WITH FDA-APPROVED SIMPLESCREEN CRC OPTION

Reuters · 4d ago

Please log in to view news